OSTEONEUROGEN INC has a total of 16 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are HWANG SUNG YEOUN, HAN POONG MODERN SCIENT HEREAL DRUGS and NAT DEVELOPMENT INSTITUTE OF KOREAN MEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 4 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special foods | |
#4 | Foods | |
#5 | Heterocyclic compounds | |
#6 | Specific use of cosmetics | |
#7 | Measuring microorganism processes | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Youn Byung Soo | 16 |
#2 | Kim Han Soo | 16 |
#3 | Yoon Ho Sup | 15 |
#4 | Kim Ik Hwan | 8 |
#5 | Kim Jun Hwan | 7 |
#6 | Ham Min Ju | 2 |
#7 | Seong Baik Lin | 2 |
#8 | Maeng Moon Kee | 2 |
#9 | Choi Hyeong Deok | 2 |
Publication | Filing date | Title |
---|---|---|
WO2017146332A1 | Novel use of chromone derivative as pharmaceutical composition for preventing and treating fibrosis by using epithelial-mesenchymal transition inhibitory activity thereof | |
WO2017146309A1 | Novel use of eupatilin as pharmaceutical composition for preventing and treating fibrosis by using epithelial-mesenchymal transition inhibitory activity thereof |